KDIGO Bundle to Prevent AKI in Sepsis

  • STATUS
    Recruiting
  • End date
    Nov 25, 2022
  • participants needed
    100
  • sponsor
    Hospital General Universitario Elche
Updated on 25 January 2021

Summary

Summary: Controlled, prospective, randomized and randomized clinical trial of two intervention groups (standard care vs. preventive recommendations the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines for AKI) of patients diagnosed with sepsis and abdominal post-surgical septic shock with positive results in the risk determination of acute renal injury by NephroCheck Test that integrates the urinary biomarkers TIMP-2 and IGFBP-7.

Hypothesis: The implementation of a package of preventive measures proposed by the KDIGO guide can reduce the occurrence and severity of acute renal injury in the high-risk abdominal post-surgical septic patient detected by urinary biomarkers for early detection.

Details
Condition Septic Acute Kidney Injury
Treatment Preventive recommendations for kidney disease: guidelines for improving overall outcomes (KDIGO) for AKI
Clinical Study IdentifierNCT04222361
SponsorHospital General Universitario Elche
Last Modified on25 January 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Patients older than 18 years
Patients (or their informed family members) who accept and sign the informed consent
Patients diagnosed with sepsis or abdominal post-surgical septic shock

Exclusion Criteria

Patients under 18 years
Patients (or their authorized relatives) who refuse to sign the informed consent
Patients diagnosed with sepsis or non-surgical septic shock
Patients diagnosed with sepsis or septic shock of origin other than abdominal
Patients with AKI stages KDIGO 2 and 3 and / or renal replacement therapy
Patients with chronic renal failure and glomerular filtration <30 ml / min and / or undergoing treatment with dialysis or previous renal transplantation
Patients with AKI of origin other than the diagnosed septic, such as glomerulonephritis or interstitial nephritis, renal artery occlusion and / or postrenal obstruction
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

0/250
Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note